VORICONAZOL ZENTIVA 200mg tablets medication leaflet

J02AC03 voriconazole • Antiinfectives for systemic use | Antimycotics for systemic use | Triazole derivatives

Voriconazole is an antifungal medication used to treat severe fungal infections, such as invasive aspergillosis, esophageal candidiasis, and other fungal infections caused by Candida or Fusarium species. It belongs to the triazole class and works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to fungal destruction.

Voriconazole is particularly indicated for immunocompromised patients, such as those with organ transplants, cancer, or other conditions that weaken the immune system. It is available in tablet form, oral suspension, or intravenous injection, and the dosage is adjusted based on the patient’s weight and the severity of the infection.

Common side effects include nausea, vomiting, abdominal pain, skin rashes, visual disturbances (such as blurred vision or light sensitivity), and elevated liver enzymes. Rarely, more serious reactions such as severe hepatotoxicity, allergic reactions, or cardiac arrhythmias may occur.

Treatment with voriconazole requires careful monitoring, including regular liver and kidney function tests. Patients should avoid prolonged sun exposure, as voriconazole can increase skin sensitivity to UV radiation. The medication should be taken as prescribed by a doctor, and dose adjustments should be made cautiously.

General data about VORICONAZOL ZENTIVA 200mg

Substance: voriconazole

Date of last drug list: 01-06-2025

Commercial code: W61628005

Concentration: 200mg

Pharmaceutical form: tablets

Quantity: 28

Product type: generic

Price: 551.73 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ZENTIVA S.A. - ROMANIA

Holder: ZENTIVA, K.S. - REPUBLICA CEHA

Number: 12103/2019/05

Shelf life: 2 years

Concentrations available for voriconazole

200mg, 40mg/ml, 50mg

Other substances similar to voriconazole

Compensation lists for VORICONAZOL ZENTIVA 200mg ZENTIVA

G10 (C1) - Leukemias, lymphomas and spinal cord aplasia, tumors

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.2 (C2) - Heart transplant

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.3 (C2) - Liver Transplant

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.5 (C2) - Pancreatic cell transplantation

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.6 (C2) - Lung transplant

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON

C3 - Sublist C - section C3 (children, pregnant women and children) with 100% discount from the reference price

Price

Copayment

Patient

551.73 RON

551.73 RON

0.00 RON